EXCEL - Experiential Cases for Empagliflozin & Linagliptin

Type 2 Diabetes patient with Hypertension and Microalbuminuria is showing clinical features of early changes of renal impairment. Listen to expert to manage inadequately controlled diabetes patients with novel emerging therapies.

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

A middle-aged person with type 2 diabetes visited the clinic with inadequate control of glycemic profile along with episodes of hypoglycemia in the recent past. Listen to the expert to achieve the optimum management of type 2 diabetes with improving tolerability profile.

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

A middle-aged person with type 2 diabetes visited the clinic with inadequate control of glycemic profile along with episodes of hypoglycemia in the recent past. Listen to the expert to achieve the optimum management of type 2 diabetes with improving tolerability profile.

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

A diabetic overweight patient with multi-organ target damage at high risk of developing heart failure is not able to achieve optimum target A1c level, what are factors we need to consider while individualizing the therapy in such patients? Listen to the expert.